{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:51:20Z","timestamp":1790077880893,"version":"4.0.1"},"reference-count":43,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2002,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Combinations of antimicrobial agents were tested against 35 strains of zygomycetes. The interaction between amphotericin B and rifampin was synergistic or additive. Flucytosine alone was inactive and, upon combination with amphotericin B, synergy was not achieved. The combination of amphotericin B with terbinafine was synergistic for 20% of strains, and the interaction between terbinafine and voriconazole was synergistic for 44% of strains. Antagonism was not observed.<\/jats:p>","DOI":"10.1128\/aac.46.8.2708-2711.2002","type":"journal-article","created":{"date-parts":[[2002,7,28]],"date-time":"2002-07-28T23:07:23Z","timestamp":1027897643000},"page":"2708-2711","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":67,"title":["In Vitro Susceptibilities of Zygomycetes to Combinations of Antimicrobial Agents"],"prefix":"10.1128","volume":"46","author":[{"given":"Eric","family":"Dannaoui","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, University Medical Center St. Radboud, 6500 HB Nijmegen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Afeltra","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, University Medical Center St. Radboud, 6500 HB Nijmegen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques F. G. M.","family":"Meis","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital, 65000 GS Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Verweij","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, University Medical Center St. Radboud, 6500 HB Nijmegen"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.11.1.21"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/41.1.59"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.8.1812"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/133.2.206"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.11.1775"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.1994.tb00103.x"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(92)90053-V"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.17.3.484"},{"key":"e_1_3_2_10_2","unstructured":"Eliopoulos G. M. and R. C. Moellering. 1991. Antimicrobial combinations p. 432-492. In V. Lorian (ed.) Antibiotics in laboratory medicine. The Williams & Wilkins Co. Baltimore Md."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"S626","DOI":"10.1093\/clinids\/5.Supplement_3.S626","volume":"5","year":"1983","unstructured":"Ernst, J. D., M. Rusnak, and M. A. Sande. 1983. Combination antifungal chemotherapy for experimental disseminated candidiasis: lack of correlation between in vitro and in vivo observations with amphotericin B and rifampin. Rev. Infect. Dis.5(Suppl. 3):S626-S630.","journal-title":"Rev. Infect. Dis."},{"key":"e_1_3_2_12_2","first-page":"289","volume":"8","year":"1997","unstructured":"Faergemann, J. 1997. Pharmacokinetics of terbinafine. Rev. Contemp. Pharmacother.8:289-298.","journal-title":"Rev. Contemp. Pharmacother."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000246260","volume":"193","year":"1996","unstructured":"Foss, N. T., M. R. Rocha, V. T. Lima, M. A. Velludo, and A. M. Roselino. 1996. Entomophthoramycosis: therapeutic success by using amphotericin B and terbinafine. Dermatology193:258-260.","journal-title":"Dermatology"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.19.1.196"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8153622"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.6.6.921-923.1999"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"S620","DOI":"10.1093\/clinids\/5.Supplement_3.S620","volume":"5","year":"1983","unstructured":"Graybill, J. R., and J. Ahrens. 1983. Interaction of rifampin with other antifungal agents in experimental murine candidiasis. Rev. Infect. Dis.5(Suppl. 3):S620-S625.","journal-title":"Rev. Infect. Dis."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.5.1256"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.9.3.593"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.25.5.560"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.9.3.406"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/clinids\/11.5.741","volume":"11","year":"1989","unstructured":"Ingram, C. W., J. Sennesh, J. N. Cooper, and J. R. Perfect. 1989. Disseminated zygomycosis: report of four cases and review. Rev. Infect. Dis.11:741-754.","journal-title":"Rev. Infect. Dis."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1080\/mmy.38.2.155.159"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/infdis\/133.6.663","volume":"133","year":"1976","unstructured":"Kitahara, M., G. S. Kobayashi, and G. Medoff. 1976. Enhanced efficacy of amphotericin B and rifampicin combined in treatment of murine histoplasmosis and blastomycosis. J. Infect. Dis.133:663-668.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.9.6.915"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.177.4050.709"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.12.1301"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1073\/pnas.69.1.196","volume":"69","year":"1972","unstructured":"Medoff, G., G. S. Kobayashi, C. N. Kwan, D. Schlessinger, and P. Venkov. 1972. Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell synergism). Proc. Natl. Acad. Sci. USA69:196-199.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.2.470-472.2000"},{"key":"e_1_3_2_30_2","unstructured":"National Committee for Clinical Laboratory Standards. 1998. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Proposed standard M38-P. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/clinids\/19.2.313","volume":"19","year":"1994","unstructured":"Ng, T. T., C. K. Campbell, M. Rothera, J. B. Houghton, D. Hughes, and D. W. Denning. 1994. Successful treatment of sinusitis caused by Cunninghamella bertholletiae. Clin. Infect. Dis.19:313-316.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/00365549109024326","volume":"23","year":"1991","unstructured":"Norden, G., S. Bjorck, H. Persson, C. Svalander, X. G. Li, and L. Edebo. 1991. Cure of zygomycosis caused by a lipase-producing Rhizopus rhizopodiformis strain in a renal transplant patient. Scand. J. Infect. Dis.23:377-382.","journal-title":"Scand. J. Infect. Dis."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.12.2670"},{"key":"e_1_3_2_34_2","first-page":"111","volume":"42","year":"1999","unstructured":"Perez, A. 1999. Terbinafine: broad new spectrum of indications in several subcutaneous and systemic and parasitic diseases. Mycoses42(Suppl. 2):111-114.","journal-title":"Mycoses"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.1999.00475.x"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.13.2.236"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.6.6.783"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/45.2.239"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1080\/mmy.39.1.91.95"},{"key":"e_1_3_2_40_2","first-page":"349","volume":"8","year":"1997","unstructured":"Schiraldi, G. F., and M. D. Colombo. 1997. Potential use of terbinafine in the treatment of aspergillosis. Rev. Contemp. Pharmacother.8:349-356.","journal-title":"Rev. Contemp. Pharmacother."},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.7.2004-2006.2000"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.11.2518"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(94)90243-7"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.3.966-968.2001"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.46.8.2708-2711.2002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.46.8.2708-2711.2002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T17:39:53Z","timestamp":1645465193000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.46.8.2708-2711.2002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["10.1128\/AAC.46.8.2708-2711.2002"],"URL":"https:\/\/doi.org\/10.1128\/aac.46.8.2708-2711.2002","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8]]},"assertion":[{"value":"2002-01-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-04-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}